Get started
Geron CorporationGeron CorporationGeron Corporation

Geron Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

GERN chart


Full chart

GERN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪910.79 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.21 USD
Net income (FY)
‪−174.57 M‬ USD
Revenue (FY)
‪76.99 M‬ USD
Shares float
‪603.39 M‬
Beta (1Y)
1.29

Employees


Employees (FY)
229
Change (1Y)
+88 +62.41%
Revenue / Employee (1Y)
‪336.22 K‬ USD
Net income / Employee (1Y)
‪−762.32 K‬ USD

About Geron Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Dawn Carter Bir
Website
geron.com
Headquarters
Foster City
Founded
1990
FIGI
BBG000GX1891
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.

Check out other big names from the same industry as GERN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GERN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of GERN is 1.39 USD — it has decreased by −4.20% in the past 24 hours. Watch Geron Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Geron Corporation stocks are traded under the ticker GERN.
GERN stock has fallen by −7.74% compared to the previous week, the month change is a −13.84% fall, over the last year Geron Corporation has showed a −69.45% decrease.
We've gathered analysts' opinions on Geron Corporation future price: according to them, GERN price has a max estimate of 6.00 USD and a min estimate of 1.50 USD. Watch GERN chart and read a more detailed Geron Corporation stock forecast: see what analysts think of Geron Corporation and suggest that you do with its stocks.
GERN reached its all-time high on Mar 3, 2000 with the price of 71.69 USD, and its all-time low was 0.75 USD and was reached on Mar 16, 2020. View more price dynamics on GERN chart.
See other stocks reaching their highest and lowest prices.
GERN stock is 5.15% volatile and has beta coefficient of 1.29. Track Geron Corporation stock price on the chart and check out the list of the most volatile stocks — is Geron Corporation there?
Today Geron Corporation has the market capitalization of ‪872.58 M‬, it has decreased by −2.58% over the last week.
Yes, you can track Geron Corporation financials in yearly and quarterly reports right on TradingView.
Geron Corporation is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
GERN earnings for the last quarter are −0.03 USD per share, whereas the estimation was −0.04 USD resulting in a 17.00% surprise. The estimated earnings for the next quarter are −0.03 USD per share. See more details about Geron Corporation earnings.
Geron Corporation revenue for the last quarter amounts to ‪39.60 M‬ USD, despite the estimated figure of ‪48.29 M‬ USD. In the next quarter, revenue is expected to reach ‪47.81 M‬ USD.
GERN net income for the last quarter is ‪−19.84 M‬ USD, while the quarter before that showed ‪−25.35 M‬ USD of net income which accounts for 21.76% change. Track more Geron Corporation financial stats to get the full picture.
No, GERN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 8, 2025, the company has 229 employees. See our rating of the largest employees — is Geron Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Geron Corporation EBITDA is ‪−133.05 M‬ USD, and current EBITDA margin is −224.06%. See more stats in Geron Corporation financial statements.
Like other stocks, GERN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Geron Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Geron Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Geron Corporation stock shows the sell signal. See more of Geron Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.